eLearning module: Improving confidence by explaining key terminology
In this expert authored eLearning module, Professor Huub Schellekens explains the key terminology commonly used when discussing biosimilars, with the aim to improve its understanding and confidence in clinical practice.
This module will take up to 20 minutes to complete.
Learning objectives
On completion of the eLearning module, you will be able to:
- Explain key terminology associated with biosimilars such as: extrapolation, interchangeability, pharmacovigilance, and traceability/labeling.
- Pass on your newly acquired knowledge of these concepts to educate other HCPs and improve confidence in biosimilars.
Target audience
All medical oncologists, specialist nurses, and allied healthcare professionals working with patients for whom biosimilars may represent a treatment option.
r Huub Schellekens MD, PhD is emeritus professor of Pharmaceutical Biotechnology at Utrecht University in the Netherlands. He studied medicine at Erasmus University in Rotterdam, The Netherlands ( 1967-1973), where he also did his training in Medical Microbiology (1976-1980) and received his PhD. in 1980.